Pages that link to "Q33908108"

The following pages link to Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. (Q33908108):

Displaying 30 items.

• Role of key TYMS polymorphisms on methotrexate therapeutic outcome in portuguese rheumatoid arthritis patients (Q21131938) (← links)
• Molecular action of methotrexate in inflammatory diseases (Q24534771) (← links)
• Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis (Q33222422) (← links)
• Prediction of methotrexate clinical response in Portuguese rheumatoid arthritis patients: implication of MTHFR rs1801133 and ATIC rs4673993 polymorphisms (Q33747444) (← links)
• The possibilities and principles of methotrexate treatment of psoriasis - the updated knowledge (Q34945967) (← links)
• Specific management of post-chikungunya rheumatic disorders: a retrospective study of 159 cases in Reunion Island from 2006-2012. (Q35168183) (← links)
• Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease (Q35377706) (← links)
• ASAS/EULAR recommendations for the management of ankylosing spondylitis (Q35637012) (← links)
• Comparison of two different folic acid doses with methotrexate--a randomized controlled trial (FOLVARI Study). (Q35789299) (← links)
• Standards of medical treatment and nutrition in Crohn's disease (Q35902007) (← links)
• Methotrexate polyglutamates as a potential marker of adherence to long-term therapy in children with juvenile idiopathic arthritis and juvenile dermatomyositis: an observational, cross-sectional study (Q36202845) (← links)
• Are dietary vitamin D, omega-3 fatty acids and folate associated with treatment results in patients with early rheumatoid arthritis? Data from a Swedish population-based prospective study (Q36397598) (← links)
• Adult-onset Still's disease: pathogenesis, clinical manifestations and therapeutic advances (Q37079113) (← links)
• Involvement of Multiple Transporters-mediated Transports in Mizoribine and Methotrexate Pharmacokinetics (Q37148784) (← links)
• Guidelines for the use of conventional and newer disease-modifying antirheumatic drugs in elderly patients with rheumatoid arthritis (Q37498849) (← links)
• Optimizing methotrexate therapy in rheumatoid arthritis: A systematic literature review (Q37858789) (← links)
• Rheumatoid arthritis and pregnancy: safety considerations in pharmacological management (Q37943826) (← links)
• Effect of Genetic Polymorphisms in the Folate Pathway on Methotrexate Therapy in Rheumatic Diseases (Q37946958) (← links)
• Optimizing pharmacotherapy of systemic lupus erythematosus: the pharmacist role (Q38225438) (← links)
• Three decades of low-dose methotrexate in rheumatoid arthritis: can we predict toxicity? (Q38267703) (← links)
• Investigating methotrexate toxicity within a randomized double-blinded, placebo-controlled trial: Rationale and design of the Cardiovascular Inflammation Reduction Trial-Adverse Events (CIRT-AE) Study (Q40298171) (← links)
• Going with the flow: methotrexate, adenosine, and blood flow (Q41850990) (← links)
• Reducing toxicity of methotrexate with folic acid (Q46555806) (← links)
• Efficacy and Safety of CH-1504, a Metabolically Stable Antifolate, in Patients with Active Rheumatoid Arthritis: Results of a Phase II Multicenter Randomized Study (Q51442740) (← links)
• Asymmetric Dimethyl Arginine as a Biomarker of Atherosclerosis in Rheumatoid Arthritis. (Q52632609) (← links)
• [Recommendations for the management of ankylosing spodylitis after ASAS/EULAR. Evaluation in the German language area] (Q79375345) (← links)
• Severe bone marrow suppression due to methotrexate toxicity following aceclofenac-induced acute kidney injury (Q89500380) (← links)
• Recent advances in understanding and managing pediatric inflammatory bowel disease (Q92310083) (← links)
• A Review of Clinical Applications and Side Effects of Methotrexate in Ophthalmology (Q98770781) (← links)
• Methotrexate-Induced Pancytopenia and Mucositis Caused by Medication Error (Q99629348) (← links)